Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

FEDERICO HINESTROSA

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1427215557
CMS profile
109771
Location
ORLANDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$38,319.28

114 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

FEDERICO HINESTROSA

NPI 1427215557 · CMS profile ID 109771

Allopathic & Osteopathic Physicians / Internal Medicine / Infectious Disease

ORLANDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1427215557?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
FEDERICO HINESTROSA, NPI 1427215557, CMS profile ID 109771. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1427215557?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). FEDERICO HINESTROSA, NPI 1427215557, CMS profile ID 109771. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1427215557?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
FEDERICO HINESTROSA, NPI 1427215557, CMS profile ID 109771, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1427215557?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

114 matching records · $38,319.28 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 114 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 114.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Theratechnologies Inc. $15.5209/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834893445 CMS
ViiV Healthcare Company $12.4309/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803217373 CMS
ViiV Healthcare Company $3,600.0008/31/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803218289 CMS
ViiV Healthcare Company $17.7708/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803217719 CMS
Janssen Biotech, Inc. $24.8808/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788224549 CMS
ViiV Healthcare Company $12.8008/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803217213 CMS
Gilead Sciences, Inc. $21.6008/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209139 CMS
ViiV Healthcare Company $124.5508/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803213247 CMS
ViiV Healthcare Company $967.4608/19/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803216037 CMS
Janssen Biotech, Inc. $18.1408/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788224541 CMS
Theratechnologies Inc. $15.6408/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834893449 CMS
Theratechnologies Inc. $750.0008/12/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834893437 CMS
Gilead Sciences, Inc. $25.9808/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209137 CMS
Merck Sharp & Dohme Corporation $18.5208/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848694779 CMS
Janssen Biotech, Inc. $21.3207/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788224537 CMS
Gilead Sciences, Inc. $30.3407/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209135 CMS
ViiV Healthcare Company $16.9507/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803216801 CMS
Gilead Sciences, Inc. $2,100.0007/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845854387 CMS
ViiV Healthcare Company $19.4607/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803217237 CMS
Gilead Sciences, Inc. $26.8007/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209133 CMS
Merck Sharp & Dohme Corporation $15.9407/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848526833 CMS
Janssen Biotech, Inc. $19.6007/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788224543 CMS
Insmed, Inc. $16.2407/08/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851735115 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.9507/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850390397 CMS
Theratechnologies Inc. $14.3607/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834893441 CMS
Gilead Sciences, Inc. $1,040.0007/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845854385 CMS
Merck Sharp & Dohme Corporation $14.4206/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848634821 CMS
Gilead Sciences, Inc. $2.3106/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209131 CMS
ViiV Healthcare Company $13.6306/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803218029 CMS
AbbVie Inc. $23.4206/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794829519 CMS
Janssen Biotech, Inc. $18.6006/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788224547 CMS
Gilead Sciences, Inc. $25.5906/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209129 CMS
Kowa Pharmaceuticals America, Inc. $32.3706/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 805490497 CMS
Theratechnologies Inc. $15.1906/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834893427 CMS
Gilead Sciences, Inc. $28.0306/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209127 CMS
Merck Sharp & Dohme Corporation $16.0906/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848597959 CMS
ViiV Healthcare Company $12.8606/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803217235 CMS
Gilead Sciences, Inc. $1,660.0005/31/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845854383 CMS
Gilead Sciences, Inc. $1,040.0005/26/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845882341 CMS
ViiV Healthcare Company $3,600.0005/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803214933 CMS
Gilead Sciences, Inc. $6.2605/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209125 CMS
ViiV Healthcare Company $19.6804/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803217939 CMS
Janssen Biotech, Inc. $17.3904/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788224533 CMS
Janssen Products, LP $29.9904/21/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788224557 CMS
Gilead Sciences, Inc. $21.7404/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209123 CMS
ViiV Healthcare Company $70.1004/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803217823 CMS
Gilead Sciences, Inc. $18.8004/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209119 CMS
Gilead Sciences, Inc. $19.3704/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209121 CMS
ViiV Healthcare Company $23.5103/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803213821 CMS
Gilead Sciences, Inc. $2.7903/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848209117 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $43,526.75 237
PY2020 $29,624.50 83
PY2021 $38,319.28 114
PY2022 $44,857.99 119
PY2023 $42,460.19 163
PY2024 $26,959.86 149
PY2025 $50,178.69 188

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,513.51 7
PY2025 Principal investigator $196,001.89 18
PY2024 Recipient $6,553.44 7
PY2024 Principal investigator $461,574.97 21
PY2023 Recipient $1,671.05 6
PY2023 Principal investigator $800,115.64 52
PY2022 Principal investigator $717,182.96 31
PY2021 Principal investigator $2,182,223.78 30
PY2020 Principal investigator $388,642.05 156
PY2019 Recipient $340.48 3
PY2019 Principal investigator $51,638.65 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $2,640.49 12/31/2025 Non-covered Recipient Entity
Orlando Immunology Center
A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Adults Living With HIV No dispute reported 06/30/2026 1232933880
Principal investigator 1 GlaxoSmithKline, LLC. $500.00 11/06/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178407
Principal investigator 1 GlaxoSmithKline, LLC. $40,377.00 10/21/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178138
Principal investigator 1 GlaxoSmithKline, LLC. $950.00 09/16/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178121
Principal investigator 1 GlaxoSmithKline, LLC. $950.00 08/14/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178412
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 07/31/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178112
Recipient ViiV Healthcare Company $40.57 07/23/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318511
Recipient ViiV Healthcare Company $16.31 07/23/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318513
Recipient ViiV Healthcare Company $16.31 07/23/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318515
Principal investigator 1 GlaxoSmithKline, LLC. $52,976.00 07/10/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178117
Principal investigator 1 GlaxoSmithKline, LLC. $1,150.00 06/25/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178403
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 06/23/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178143
Recipient ViiV Healthcare Company $637.22 06/17/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318509
Recipient ViiV Healthcare Company $152.48 06/17/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318777
Recipient ViiV Healthcare Company $325.31 06/17/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318779
Recipient ViiV Healthcare Company $325.31 06/17/2025 Covered Recipient Physician AN EXPLORATORY PHASE 1B, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO No dispute reported 06/30/2026 1190318781
Principal investigator 1 GlaxoSmithKline, LLC. $61,506.00 05/02/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192174512
Principal investigator 1 GlaxoSmithKline, LLC. $150.00 03/28/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192174517
Principal investigator 1 GlaxoSmithKline, LLC. $900.00 03/28/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178148
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 03/21/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192174522
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 03/21/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178135
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 03/21/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178398
Principal investigator 1 GlaxoSmithKline, LLC. $504.90 03/21/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178417
Principal investigator 1 ABBVIE INC. $3,100.00 02/13/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER PA
M20-350 - Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE) Pibrentasvir (PIB) No dispute reported 06/30/2026 1202451247
Principal investigator 1 GlaxoSmithKline, LLC. $27,773.00 01/28/2025 Non-covered Recipient Entity
ORLANDO IMMUNOLOGY CENTER
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO A No dispute reported 06/30/2026 1192178127